A kind of HPLC analysis method of hydroxychloroquine sulfate and its related substances

Through the combination of the mobile phase system of perchloric acid and acetonitrile and phenyl column, the gradient elution method is used to solve the problems of insufficient impurity detection and chromatographic column damage in hydroxychloroquine sulfate analysis, achieving high precision and high reproducibility HPLC analysis is suitable for the analysis of raw materials and preparations.

CN114062520BActive Publication Date: 2024-11-29SHANGHAI ZHONGXI PHARMACEUTICAL CO LTD +1
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202010750014.0
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2020-07-30
Publication Date
2024-11-29
Estimated Expiration
2040-07-30

AI Technical Summary

Technical Problem

The existing HPLC analysis methods for hydroxychloroquine sulfate and its related substances have the problem of small amounts of impurities, complex mobile phase system and possible damage to the chromatographic column, making it difficult to achieve high precision and high reproducibility analysis.

Method used

Perchloric acid and acetonitrile are used as mobile phase systems and phenyl columns are chromatographic columns. HPLC analysis is performed through gradient elution method to ensure short detection time, high precision and good reproducibility. It can be used for subsequent LC-MS measurements. .

Benefits of technology

It realizes simultaneous detection and separation of hydroxychloroquine sulfuric acid and its 12 related substances. The mobile phase system is simple and does not damage the instrument or chromatographic column. It is simple to operate, has high precision, high sensitivity, high accuracy and low cost.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114062520B_ABST
    Figure CN114062520B_ABST
Patent Text Reader

Abstract

The invention discloses an HPLC analysis method for hydroxychloroquine sulfate and related substances thereof, and the steps include: dissolving a test substance in a solution containing perchloric acid, and performing HPLC detection; the chromatographic conditions are: the mobile phase includes mobile phase A and mobile phase B; the mobile phase A is a perchloric acid solution; the mobile phase B is acetonitrile; and the chromatographic column is a phenyl column. The method of the invention can simultaneously detect hydroxychloroquine sulfate and 12 related substances and their contents, and realizes the effective separation of hydroxychloroquine sulfate and its related substances; the mobile phase system is simple and will not cause damage to the instrument or the chromatographic column, and the operation is simple, the precision is high, the reproducibility is good, the sensitivity is high, the accuracy is high, and the cost is low.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a HPLC analysis method for hydroxychloroquine sulfate and related substances thereof. Background Art

[0002] Hydroxychloroquine sulfate, chemical name: 2-[[4-[(7-chloro-4-quinolyl)amino]pentyl]ethylamino]-ethanol sulfate, is an antimalarial agent, usually used to treat rheumatoid arthritis, systemic lupus erythematosus, sarcoidosis and other diseases. Hydroxychloroquine sulfate has a good oral effect and can be quickly and completely absorbed by the human body. Therefore, hydroxychloroquine sulfate is a chloroquine-like antimalarial drug that is currently widely used in clinical practice.

[0003] At present, although some documents and pharmacopoeias have been reported about the analytical method of hydroxychloroquine sulfate and related substances, there are some defects. Specifically as follows: European Pharmacopoeia (EP) adopts UPLC liquid phase method to measure impurity content in hydroxychloroquine sulfate, which adopts the sodium heptane sulfonate ion pair system containing triethylamine, and there is poor reproducibility in this method, and the impurity detected has only 6, and there is no baseline separation between impurities and impurities, low sensitivity and narrow impurity analysis range (see the quality control standard for impurity detection in drug registration application standards and pharmacopoeia). Richard R etc. (Richard R.Brown, Ronald M.Stroshane, David P.Benziger, Journal of Chromatography, 377 (1986) 454-459) adopt CN column (150*4.6mm, 6μm) was used to perform HPLC analysis on the metabolites of hydroxychloroquine sulfate plasma, UV320nm wavelength, flow rate 1.2mL / min, and mobile phase 0.06M dibutylamine phosphate-0.05M disodium hydrogen phosphate = 40:60 (pH adjusted to 3.5 with phosphoric acid). Results Although this analytical method successfully achieved the analysis of related substances in plasma, the problem was that the concentration of plasma samples was low, and the method could not achieve analysis for conventional related substances; and the life cycle of the cyano chromatographic column itself was shorter than that of other chromatographic columns, and the use of this concentration of phosphate was more harmful to the cyano chromatographic column. In addition, there are many literature reports on the analysis of hydroxychloroquine sulfate in biological samples, and the reference value provided for hydroxychloroquine sulfate in raw materials or finished preparations is low.

[0004] In summary, due to certain defects in the current analytical methods, there is an urgent need to develop a HPLC (high performance liquid chromatography) analytical method for hydroxychloroquine sulfate with short detection time, high precision, good reproducibility, and effective separation of existing impurities (as shown in Table 1, including European Pharmacopoeia, commercially available process intermediates or degradation impurities, etc.).

[0005] Table 1 Chemical names and structures of impurities

[0006]

[0007]

[0008] Note: The naming of hydroxychloroquine sulfate impurities A, B, C, D, E, F and G is consistent with the European Pharmacopoeia impurity naming.

[0009] In the above table, the most difficult separation of hydroxychloroquine sulfate from related substances is the separation of impurity 6 and impurity 9 from the main peak. In addition, the separation of impurities 7, 8 and the main peak or impurities 5, 6 and the main peak is also difficult, and there is currently no method that can simultaneously detect and separate the 12 impurities and hydroxychloroquine sulfate in the above table. Summary of the invention

[0010] The invention provides a HPLC analysis method for hydroxychloroquine sulfate and its related substances in order to solve the problems that the number of impurities that can be detected at the same time is small, the mobile phase system is complex and irreversible damage to the instrument or the chromatographic column may be caused in the analysis method for hydroxychloroquine sulfate and its related substances in the prior art.

[0011] Applicant finds, adopts the C18 with wider pH range as chromatographic column, with aqueous phosphoric acid-acetonitrile system as mobile phase, at suitable detection wavelength and flow velocity, the part related substance in hydroxychloroquine sulfate can be carried out effective chromatographic analysis, but analytical process can cause chromatographic peak wider, affect the separation of individual impurity (such as hydroxychloroquine sulfate impurity D in European Pharmacopoeia, hydroxychloroquine sulfate impurity A, hydroxychloroquine sulfate impurity B), can't accurately separate and analyze hydroxychloroquine sulfate and related substance thereof.Found through the creative work of the inventor, adopt the solution containing perchloric acid as solvent, perchloric acid and acetonitrile are mobile phase system, phenyl column is that chromatographic column carries out liquid chromatography method analysis, 12 kinds of related substances and content thereof in hydroxychloroquine sulfate and table 1 can be detected simultaneously, mobile phase system is simple and can not bring damage to instrument or chromatographic column, detection time is short, precision is high, good reproducibility, accuracy is high, cost is low, this system also can be used for follow-up LC-MS to measure, for some follow-up research works of hydroxychloroquine sulfate are carried out to create favorable conditions.

[0012] The present invention solves the above technical problems through the following technical solutions.

[0013] The present invention provides an HPLC analysis method for hydroxychloroquine sulfate and related substances thereof, the steps of which include: dissolving the test substance in a solution containing perchloric acid, and performing HPLC detection;

[0014] The chromatographic conditions are:

[0015] The mobile phase includes mobile phase A and mobile phase B; the mobile phase A is a perchloric acid solution; the mobile phase B is acetonitrile;

[0016] The chromatographic column is a phenyl column.

[0017] In the present invention, the solution containing perchloric acid is preferably an aqueous solution containing perchloric acid and acetonitrile, wherein the volume ratio of perchloric acid:acetonitrile:water is preferably 0.05:(10-30):(70-90), for example, 0.05:10:90, 0.05:20:80 or 0.05:30:70.

[0018] In the present invention, when the HPLC test is performed, the concentration of the solution obtained after the test substance is dissolved is preferably 0.00002-0.5 mg / mL, more preferably 0.0001-0.24 mg / mL, for example 0.2 mg / mL. When the concentration of the solution obtained is 0.0001-0.24 mg / mL, the separation degree can reach more than 1.5.

[0019] In the present invention, the mobile phase A is preferably a perchloric acid solution with a volume fraction of 0.1% to 0.3%, more preferably a perchloric acid solution with a volume fraction of 0.1%. When the mobile phase A is a perchloric acid solution with a volume fraction of 0.1%, the separation degree can reach more than 1.7.

[0020] In the present invention, the chromatographic column is preferably a phenylbutyl bonded chromatographic column, and its model may be YMC-TriartPhenyl 150*4.6mm ID S-3um, 12nm.

[0021] In the present invention, the length of the chromatographic column is preferably 150 mm to 250 mm, for example, 150 mm. The inner diameter of the chromatographic column is preferably 4.6 mm. The particle size of the filler particles of the chromatographic column is preferably 3 μm to 5 μm. The micropore diameter of the chromatographic column is preferably 12 nm.

[0022] In the present invention, the flow rate of the mobile phase is preferably 0.8-1.2 mL / min, for example 1.0 mL / min.

[0023] In the present invention, in the HPLC detection, the detection wavelength is preferably 220 nm to 300 nm, for example, 220 nm.

[0024] In the present invention, in the HPLC detection, the column temperature is preferably 20-30°C, for example, 25°C.

[0025] In the present invention, in the HPLC detection, the injection volume is preferably 5 to 20 μL, for example, 10 μL.

[0026] In the present invention, in the HPLC detection, the elution mode is preferably gradient elution. More preferably, in the gradient elution, the total volume of the mobile phase is 100%; at 0 min, the volume fraction of the mobile phase A is 50% to 88%, and more preferably 88%, which can shorten the analysis time and improve the analysis efficiency while ensuring baseline separation. In a specific embodiment, in the gradient elution, the total volume of the mobile phase A is 100%; at 0 min, the volume fraction of the mobile phase A is 88%; at 0-6 min, the volume fraction of the mobile phase A is 88%; at 6-26 min, the volume fraction of the mobile phase A decreases to 80%; at 26-31 min, the volume fraction of the mobile phase A decreases to 65%; at 31-36 min, the volume fraction of the mobile phase A is 65%; at 36-37 min, the volume fraction of the mobile phase A decreases to 50%, and at 37-40 min, the volume fraction of the mobile phase A is 50%; at 40-40.1 min, the volume fraction of the mobile phase A increases to 88%; at 40.1-45 min, the volume fraction of the mobile phase A is 88%.

[0027] In the present invention, after the test substance is dissolved in a solution containing perchloric acid, centrifugation and / or filtration may be performed if necessary. The centrifugal conditions may be conventional in the art, the centrifugal time is generally 5 to 10 minutes, for example, 5 minutes, and the centrifugal speed is generally 5000 to 8000 rpm, for example, 5000 rpm. The filtering conditions may be conventional in the art, and generally a microporous filter membrane may be used for filtration, and the material of the microporous filter membrane is preferably nylon, polytetrafluoroethylene PTFE or polyvinylidene fluoride PVDF.

[0028] The present invention also provides an application of the HPLC analysis method of hydroxychloroquine sulfate and its related substances as described above, which is used for the analysis of raw materials and related preparation products (such as tablets, capsules, ointments, etc.).

[0029] On the basis of being in accordance with the common sense in the art, the above-mentioned preferred conditions can be arbitrarily combined to obtain the preferred embodiments of the present invention.

[0030] The reagents and raw materials used in the present invention are commercially available.

[0031] The positive and progressive effects of the present invention are:

[0032] The invention adopts a perchloric acid-containing solution as a solvent, perchloric acid and acetonitrile as a mobile phase system, and a phenyl column as a chromatographic column to perform liquid chromatography analysis, and measures the content of hydroxychloroquine sulfate by an external standard method and measures the content of related substances of hydroxychloroquine sulfate by a main component self-control method, and can simultaneously detect hydroxychloroquine sulfate and 12 related substances in Table 1 and their contents, thereby achieving effective separation of hydroxychloroquine sulfate and its related substances; the mobile phase system is simple and does not cause damage to an instrument or a chromatographic column, and the operation is simple, and the precision is high, the reproducibility is good, the sensitivity is high, the accuracy is high, and the cost is low.

[0033] In a preferred embodiment of the present invention, the problem that hydroxychloroquine sulfate requires a higher concentration for content detection and the asymmetric content peak shape can be improved, and the separation degree is good. BRIEF DESCRIPTION OF THE DRAWINGS

[0034] Figure 1 The HPLC chromatogram of Example 1 is shown in FIG.

[0035] Figure 2 The HPLC chromatogram of Example 2 is shown in FIG.

[0036] Figure 3 The HPLC chromatogram of Example 3 is shown in FIG.

[0037] Figure 4 It is the HPLC chromatogram of Example 4.

[0038] Figure 5 It is the HPLC chromatogram of Comparative Example 1.

[0039] Figure 6 It is the HPLC chromatogram of Comparative Example 2.

[0040] Figure 7 It is the HPLC chromatogram of Comparative Example 3.

[0041] Figure 8 It is the HPLC chromatogram of Comparative Example 4. DETAILED DESCRIPTION

[0042] The present invention is further described below by way of examples, but the present invention is not limited to the scope of the examples. The experimental methods in the following examples without specifying specific conditions are carried out according to conventional methods and conditions, or selected according to the product specifications.

[0043] The instruments and drugs used in the following examples are as follows:

[0044] The HPLC instrument was Agilent 1260, the UV detector was DAD, the chromatographic column was YMC-Triart Phenyl 150*4.6mm ID S-3um, 12nm, electronic analytical balance (Mettler XS105 analytical balance, one hundred thousandth; Mettler XRP2 analytical balance, one millionth), CNC ultrasonic cleaner (Kunshan Ultrasonic Instrument Co., Ltd.), ultrapure water instrument (Merck Millipore Direct 8 / 16 Pure Water System), hydroxychloroquine sulfate raw material (Shanghai Shangyao Zhongxi Pharmaceutical Co., Ltd., batch number S180201), perchloric acid, acetonitrile and hydroxychloroquine sulfate blank excipients, filter membrane models: PVDF (polyvinylidene fluoride membrane, 25mm*0.45μm), PTFE (polytetrafluoroethylene membrane, 25mm*0.45μm), nylon (polyamide, 25mm*0.45μm).

[0045] In the following examples, the preparation process and testing method of the sample solution to be tested are as follows:

[0046] 1) preparing a hydroxychloroquine sulfate standard product into a solution with a concentration of 0.1 μg / mL to 200 μg / mL using a solvent. Obtaining the relationship between the concentration of hydroxychloroquine sulfate and the area through chromatographic analysis;

[0047] 2) preparing a solution of hydroxychloroquine sulfate (or hydroxychloroquine sulfate and related substances) with a certain concentration by using a solvent. Obtaining the peak area of ​​hydroxychloroquine sulfate or related substances in the sample by chromatographic analysis;

[0048] 3) Dilute hydroxychloroquine sulfate with a solvent to form a 2 μg / mL control solution.

[0049] The sample solutions 1), 2), and 3) prepared in step (1) are injected into HPLC respectively, and a spectrum is obtained after detection and analyzed, and the content of hydroxychloroquine sulfate is obtained by an external standard method; and the content of related substances in hydroxychloroquine sulfate is obtained by a self-control method. Among them, the components of the "solvent" in the sample solutions 1), 2), and 3) need to be consistent.

[0050] Example 1

[0051] Investigate the influence of different filter membranes on test results

[0052] Prepare a solution of 0.2mg / mL of hydroxychloroquine sulfate, centrifuge supernatant (5000 turns, centrifugal 5 minutes) and 0.45μm microporous filter membrane of different materials (the size and pore size of polyvinylidene fluoride membrane PVDF are 25mm*0.45μm, the size and pore size of polytetrafluoroethylene membrane PTFE are 25mm*0.45μm, and the size and pore size of polyamide Nylon are 25mm*0.45μm) filter. The solvent for dissolving hydroxychloroquine sulfate here is a solution containing perchloric acid (perchloric acid: acetonitrile; water=0.05:10:90; v / v / v).

[0053] YMC-Triart Phenyl 150*4.6mm ID S-3um, 12nm was used as the chromatographic column, and the mobile phase was 0.1% perchloric acid-acetonitrile for gradient elution. The elution program was:

[0054] Time (min) A(%) B(%) 0.00 88.0 12.0 6.00 88.0 12.0 26.00 80.0 20.0 31.00 65.0 35.0 36.00 65.0 35.0 37.00 50.0 50.0 40.00 50.0 50.0 40.10 88.0 12.0 45.00 88.0 12.0

[0055] The detection wavelength was 220 nm, the flow rate was 1 mL / min, the column temperature was 25° C., the injection volume was 10 μL, and a chromatographic analysis graph was obtained.

[0056] The test results show that PVDF, PTFE and Nylon filter membranes have no adsorption, and the content results are all between 98.0% and 102.0% (as shown in Table 2 and Figure 1 shown).

[0057] Table 2

[0058] name Peak area Recovery rate (%) Test sample (centrifugation only) 8524.76 N / A Test sample (PVDF membrane filtration) 8538.94 100.2 Test sample (PTFE membrane filtration) 8543.75 100.2 Test sample (Nylon membrane filtration) 8551.70 100.3

[0059] Note: “N / A” means not applicable.

[0060] Example 2

[0061] The effect of solvent on the separation of hydroxychloroquine sulfate and its related substances was investigated.

[0062] A 0.2 mg / mL solution of hydroxychloroquine sulfate and related substances (the concentration of the impurity solution is 20 μg / mL) was prepared, dissolved in different solvents a to d, and then centrifuged to obtain the supernatant (5000 rpm, 5 minutes) for testing.

[0063] Solvent: a) H2O: ACN: HClO4 = 80: 20: 0.05 (v / v / v); b) H2O: ACN: HClO4 = 90: 10: 0.05 (v / v / v); c) H2O: ACN=90: 10 (v / v); d) H2O: ACN: HClO4=70: 30: 0.05 (v / v / v).

[0064] YMC-Triart Phenyl 150*4.6mm ID S-3um, 12nm was used as the chromatographic column, and the mobile phase was 0.1% perchloric acid-acetonitrile for gradient elution. The elution program was:

[0065] Time (min) A(%) B(%) 0.00 88.0 12.0 6.00 88.0 12.0 26.00 80.0 20.0 31.00 65.0 35.0 36.00 65.0 35.0 37.00 50.0 50.0 40.00 50.0 50.0 40.10 88.0 12.0 45.00 88.0 12.0

[0066] The detection wavelength was 220 nm, the flow rate was 1 mL / min, the column temperature was 25° C., the injection volume was 10 μL, and a chromatographic analysis graph was obtained.

[0067] The test results show that when a solution containing perchloric acid is used as the solvent, 12 impurities can be effectively separated with good separation. Figure 2 As shown in Table 3, when using solvent c that does not contain perchloric acid, most impurities can achieve effective baseline separation, but individual impurities (the impurity numbers in Table 3 correspond to the chemical names and structures in Table 1, and the two impurities numbered 10 / 11, namely, the impurity 4,7-dichloroquinoline and hydroxychloroquine sulfate impurity F in Table 1) cannot be separated.

[0068] Table 3

[0069]

[0070]

[0071] Note: “N / A” means not applicable.

[0072] Example 3

[0073] Investigating the effect of hydroxychloroquine sulfate concentration on the separation of hydroxychloroquine sulfate and its related substances

[0074] Prepare 0.5mg / mL of hydroxychloroquine sulfate solution (the hydroxychloroquine sulfate bulk drug adopted in the embodiment all contains impurity 6 in Table 1, i.e. hydroxychloroquine sulfate impurity D in the European Pharmacopoeia), centrifuge and take supernatant (5000 turns, centrifugal 5 minutes).The solvent dissolved here is a solution containing perchloric acid (perchloric acid: acetonitrile; water=0.05:10:90; v / v / v).

[0075] YMC-Triart Phenyl 150*4.6mm ID S-3um, 12nm was used as the chromatographic column, and the mobile phase was 0.1% perchloric acid-acetonitrile for gradient elution. The elution program was:

[0076]

[0077]

[0078] The detection wavelength was 220 nm, the flow rate was 1 mL / min, the column temperature was 25° C., the injection volume was 10 μL, and a chromatographic analysis graph was obtained.

[0079] When the concentration of hydroxychloroquine sulfate solution was 0.5 mg / mL, baseline separation could be achieved and 12 related substances were basically separated. Figure 3 As shown in Table 4 (the impurity numbers in Table 4 correspond to the chemical names and structures in Table 1), its peak shape is worse than that in Example 4, the peak is extended, the tailing factor is 3.0, the separation degree between the main peak HCQ impurity (impurity 6, i.e., hydroxychloroquine sulfate impurity D) and the main peak is 1.1, and the hydroxychloroquine sulfate peak area is as high as 21000.

[0080] Table 4

[0081] Peak name Retention time Separation Impurity 6 23.165 N / A Hydroxychloroquine sulfate HCQ 23.725 1.1

[0082] Example 4

[0083] A 0.2 mg / mL solution of hydroxychloroquine sulfate and related substances was prepared (the concentration of the impurity solution was 20 μg / mL). The dissolving medium was a solution containing perchloric acid (perchloric acid: acetonitrile; water = 0.05:10:90; v / v / v).

[0084] YMC-Triart Phenyl 150*4.6mm ID S-3um, 12nm was used as the chromatographic column, and the mobile phase was 0.1% perchloric acid-acetonitrile for gradient elution. The elution program was:

[0085]

[0086]

[0087] The detection wavelength was 220 nm, the flow rate was 1 mL / min, the column temperature was 25° C., the injection volume was 10 μL, and a chromatographic analysis graph was obtained.

[0088] like Figure 4 As shown in Table 5 (the impurity numbers in Table 5 correspond to the chemical names and structures in Table 1), the minimum separation degree of the related substances of hydroxychloroquine sulfate is 1.7, baseline separation is achieved, the analysis time is moderate, and the analysis of the related substances of hydroxychloroquine sulfate is achieved.

[0089] Table 5

[0090] Impurity No. Retention time Separation Impurity 1 11.702 N / A Impurity 2 18.763 19.9 Impurity 3 20.214 4.0 Impurity 4 21.133 2.6 Impurity 5 22.237 3.2 Impurity 6 23.162 2.4 Hydroxychloroquine sulfate HCQ 24.010 1.7 Impurity 7 26.811 5.8 Impurity 8 27.746 2.4 Impurity 9 31.010 10.3 Impurity 10 36.474 23.5 Impurity 11 37.220 2.6 Impurity 12 38.921 5.0

[0091] Note: “N / A” means not applicable.

[0092] Example 5

[0093] Methodological investigation of the related substances of hydroxychloroquine sulfate determined by the present invention

[0094] 1. Exclusive inspection

[0095] Prepare 0.2mg / mL hydroxychloroquine sulfate solution, centrifuge and take supernatant, take blank solvent, blank auxiliary material solution and each 10 μL of need testing solution respectively, inject liquid chromatography system, adopt the analytical method of embodiment 4, test result finds blank solvent, blank auxiliary material peak does not interfere with the peak of hydroxychloroquine sulfate and the peak of related substances, can give and reach complete baseline separation.Here dissolving solvent is perchloric acid: water: acetonitrile = 0.05:90:10 (v / v / v).

[0096] 2. Linear relationship investigation

[0097] Prepare respectively with 0.2mg / mL as 100%, linear level is respectively 120%, 100%, 80% and 2%, 1.5%, 1%, 0.5%, 0.05% concentration of hydroxychloroquine sulfate solution, detect according to embodiment 4 chromatographic conditions, sample size is 10 μ L.The concentration of hydroxychloroquine sulfate and peak area show good linear relationship in 0.05%~120% linear range, and correlation coefficient meets and is not less than 0.997.Here dissolving solvent is perchloric acid: water: acetonitrile=0.05:90:10 (v / v / v).

[0098] 3. Detection limit investigation

[0099] Prepare a 0.01% detection limit concentration hydroxychloroquine sulfate solution with 0.2 mg / mL as 100%, a detection limit concentration test sample with a concentration of 0.02 μg / mL, and detect according to the chromatographic conditions of Example 4, the injection volume is 10 μL, and 3 portions are prepared respectively. The detection limit signal-to-noise ratio is greater than 3, indicating that the analytical method is good and has high reproducibility. The dissolving solvent here is perchloric acid: water: acetonitrile = 0.05:90:10 (v / v / v).

[0100] 4. Investigation of the accuracy of analytical methods

[0101] The lowest response impurity was prepared, and its 0.05% quantitative limit concentration impurity solution (concentration: 0.0001mg / mL) was prepared in triplicate. The average recovery rate of the spiked sample was 101.3%, and the lowest single recovery rate was 98.8%. This shows that the accuracy of the analytical method is good and the reproducibility is also high. The dissolving solvent here is perchloric acid: water: acetonitrile = 0.05:90:10 (v / v / v).

[0102] Comparative Example 1

[0103] A C18 chromatographic column was used, and the mobile phase was 0.1% phosphoric acid-acetonitrile for gradient elution. The remaining operation and test conditions were the same as in Example 4. The results are shown in FIG. Figure 5 shown.

[0104] It was found that hydroxychloroquine sulfate and the impurity 6 in Example 4 could not be separated.

[0105] Comparative Example 2

[0106] A C18 chromatographic column was used, and the mobile phase was potassium dihydrogen phosphate-acetonitrile for gradient elution. The remaining operation and test conditions were the same as in Example 4. The results are shown in FIG. Figure 6 shown.

[0107] It was found that hydroxychloroquine sulfate and the impurity 6 in Example 4 could not be separated.

[0108] Comparative Example 3

[0109] YMC-Triart Phenyl 150*4.6mm ID S-3um, 12nm was used as the chromatographic column, and the mobile phase was 0.1% trifluoroacetic acid-acetonitrile for gradient elution. The remaining operation and test conditions were the same as in Example 4. The results are shown in FIG. Figure 7 shown.

[0110] It was found that hydroxychloroquine sulfate and impurities 6 and 9 in Example 4 could not be separated.

[0111] Comparative Example 4

[0112] YMC-Triart Phenyl 150*4.6mm ID S-3um, 12nm was used as the chromatographic column, and the mobile phase was 0.1% phosphoric acid-acetonitrile for gradient elution. The remaining operation and test conditions were the same as in Example 4. The results are shown in FIG. Figure 8 shown.

[0113] It was found that hydroxychloroquine sulfate and the impurity 6 in Example 4 could not be separated.

Claims

1. A HPLC analysis method for hydroxychloroquine sulfate and its related substances, It is characterized in that The steps include: dissolving the test substance in a solution containing perchloric acid and performing HPLC detection; The perchloric acid-containing solution is an aqueous solution containing perchloric acid and acetonitrile; wherein the volume ratio of perchloric acid:acetonitrile:water is 0.05:(10-30):(70-90); During the HPLC test, after the test substance is dissolved, the concentration of the obtained solution is 0.0001 to 0.24 mg / mL; The chromatographic conditions are: The mobile phase includes mobile phase A and mobile phase B; the mobile phase A is a perchloric acid solution with a volume fraction of 0.1% to 0.3%; the mobile phase B is acetonitrile; the flow rate of the mobile phase is 0.8 to 1.2 mL / min; In the HPLC detection, the detection wavelength is 220nm-300nm; the column temperature is 20-30°C; the elution mode is gradient elution; in the gradient elution, the total volume of the mobile phase is 100%; at 0min, the volume fraction of the mobile phase A is 88%; at 0-6min, the volume fraction of the mobile phase A is 88%; at 6-26min, the volume fraction of the mobile phase A decreases to 80%; At 26-31 min, the volume fraction of the mobile phase A decreases to 65%; at 31-36 min, the volume fraction of the mobile phase A is 65%; at 36-37 min, the volume fraction of the mobile phase A decreases to 50%, and at 37-40 min, the volume fraction of the mobile phase A is 50%; at 40-40.1 min, the volume fraction of the mobile phase A increases to 88%; at 40.1-45 min, the volume fraction of the mobile phase A is 88%; the structures of the related substances are shown in the following table: The chromatographic column is a phenylbutyl bonded chromatographic column; the length of the phenylbutyl bonded chromatographic column is 150 mm to 250 mm; the inner diameter of the phenylbutyl bonded chromatographic column is 4.6 mm; the particle size of the filler particles of the phenylbutyl bonded chromatographic column is 3 μm to 5 μm; and the micropore diameter of the phenylbutyl bonded chromatographic column is 12 nm.

2. the HPLC analytical method of hydroxychloroquine sulfate and its related substances as claimed in claim 1, It is characterized in that The volume ratio of perchloric acid:acetonitrile:water is 0.05:10:90, 0.05:20:80 or 0.05:30:

70.

3. the HPLC analytical method of hydroxychloroquine sulfate and its related substances as claimed in claim 1, It is characterized in that During the HPLC test, after the test substance was dissolved, the concentration of the obtained solution was 0.2 mg / mL.

4. the HPLC analytical method of hydroxychloroquine sulfate and its related substances as claimed in claim 1, It is characterized in that The mobile phase A is a perchloric acid solution with a volume fraction of 0.1%.

5. the HPLC analytical method of hydroxychloroquine sulfate and its related substances as claimed in claim 1, It is characterized in that The model of the chromatographic column is YMC-Triart Phenyl 150*4.6mm ID, and the particle size of the filler particles of the chromatographic column is 3 μm.

6. the HPLC analytical method of hydroxychloroquine sulfate and its related substances as claimed in claim 1, It is characterized in that In the HPLC detection, the injection volume is 5 to 20 μL.

7. the HPLC analytical method of hydroxychloroquine sulfate and its related substances as claimed in claim 1, It is characterized in that After the test substance is dissolved in a solution containing perchloric acid, centrifugation and / or filtration is performed.

8. the HPLC analytical method of hydroxychloroquine sulfate and its related substances as claimed in claim 7, It is characterized in that The centrifugation time is 5 to 10 minutes; And / or, the centrifugal speed is 5000-8000 rpm; And / or, filtering is performed using a microporous membrane.

9. the HPLC analytical method of hydroxychloroquine sulfate and its related substances as claimed in claim 8, It is characterized in that The material of the microporous filter membrane is nylon, polytetrafluoroethylene PTFE or polyvinylidene fluoride PVDF.

10. An application of the HPLC analysis method of hydroxychloroquine sulfate and its related substances as described in any one of claims 1 to 9, It is characterized in that It is used for the analysis of hydroxychloroquine sulfate raw materials and its related preparations.

Citation Information

Patent Citations

  • Method for analysis of hydroxychloroquine sulfate raw material and preparation by high performance liquid chromatography

    CN103472154A